These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. COVID-19 vaccination including 198 patients with history of severe anaphylactic reaction - own observations. Wentrys Ł; Stopyra L Przegl Epidemiol; 2021; 75(3):315-325. PubMed ID: 35170287 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 and allergy - what have we learned after two and a half years? Brockow K; Wang R; Mathes S; Bent R; Faihs V; Eberlein B; Darsow U; Biedermann T Allergol Select; 2023; 7():101-112. PubMed ID: 37056446 [TBL] [Abstract][Full Text] [Related]
8. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis. Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. Warren CM; Snow TT; Lee AS; Shah MM; Heider A; Blomkalns A; Betts B; Buzzanco AS; Gonzalez J; Chinthrajah RS; Do E; Chang I; Dunham D; Lee G; O'Hara R; Park H; Shamji MH; Schilling L; Sindher SB; Sisodiya D; Smith E; Tsai M; Galli SJ; Akdis C; Nadeau KC JAMA Netw Open; 2021 Sep; 4(9):e2125524. PubMed ID: 34533570 [TBL] [Abstract][Full Text] [Related]
12. Immediate Adverse Events Following COVID-19 Vaccination in Australian Pharmacies: A Retrospective Review. Gallo AT; Scanlon L; Clifford J; Patten-Williams L; Tweedie L; Li D; Salter SM Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560451 [TBL] [Abstract][Full Text] [Related]
13. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI. Klimek L; Bergmann KC; Brehler R; Pfützner W; Zuberbier T; Hartmann K; Jakob T; Novak N; Ring J; Merk H; Hamelmann E; Ankermann T; Schmidt S; Untersmayr E; Hötzenecker W; Jensen-Jarolim E; Brockow K; Mahler V; Worm M Allergo J Int; 2021; 30(3):79-95. PubMed ID: 33898162 [TBL] [Abstract][Full Text] [Related]
14. Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis. Alhumaid S; Al Mutair A; Al Alawi Z; Rabaan AA; Tirupathi R; Alomari MA; Alshakhes AS; Alshawi AM; Ahmed GY; Almusabeh HM; Alghareeb TT; Alghuwainem AA; Alsulaiman ZA; Alabdulmuhsin MA; AlBuwaidi EA; Dukhi AKB; Mufti HN; Al-Qahtani M; Dhama K; Al-Tawfiq JA; Al-Omari A Allergy Asthma Clin Immunol; 2021 Oct; 17(1):109. PubMed ID: 34656181 [TBL] [Abstract][Full Text] [Related]
15. AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy. Ali SB; Perkins G; Ryoo D; Lee M; Tunbridge M; Yuson C; Smith W; Hissaria P; Le TT Allergy Asthma Clin Immunol; 2022 Mar; 18(1):22. PubMed ID: 35272714 [TBL] [Abstract][Full Text] [Related]
16. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021. Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813 [TBL] [Abstract][Full Text] [Related]
17. Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID-19 vaccinations, Western Australia, 22 February to 30 June 2021. Shivarev A; Phillips A; Brophy-Williams S; Ford T; Richmond P; Effler P; McLean-Tooke A Intern Med J; 2023 Feb; 53(2):275-279. PubMed ID: 36585764 [TBL] [Abstract][Full Text] [Related]
18. Analysis of spontaneous reports of suspected adverse reactions after vaccination against COVID-19 in Slovakia. Lassanova M; Lassan S; Liskova S; Tesar T; Cicova M Front Pharmacol; 2023; 14():1097890. PubMed ID: 36726587 [No Abstract] [Full Text] [Related]
19. [Anaphylactic reactions to vaccines : Chicken egg allergy and the influenza H1N1 vaccination]. Klimek L; Wicht-Langhammer S; von Bernus L; Thorn C; Cazan D; Pfaar O; Hörmann K HNO; 2017 Oct; 65(10):834-839. PubMed ID: 28540396 [TBL] [Abstract][Full Text] [Related]
20. Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events. Kobayashi H; Fukuda S; Matsukawa R; Asakura Y; Kanno Y; Hatta T; Saito Y; Shimizu Y; Kawarasaki S; Kihara M; Kinoshita N; Umeda H; Noda T; Imamura T; Nishioka Y; Yamaguchi T; Hayashi S; Iguchi T Ther Innov Regul Sci; 2023 Mar; 57(2):329-342. PubMed ID: 36310329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]